Literature DB >> 10737907

Energy/temperature diagram and compression behavior of the polymorphs of D-mannitol.

A Burger1, J O Henck, S Hetz, J M Rollinger, A A Weissnicht, H Stöttner.   

Abstract

Three modifications of D-mannitol were produced and investigated: mod. I (mp 166.5 degrees C, heat of fusion 53.5 kJ mol(-1)), mod. II (mp 166 degrees C, heat of fusion 52.1 kJ mol(-1)), and mod. III (mp incongruent 150-158 degrees C, heat of transition, III to I 0.2 kJ mol(-1)). The measured densities are 1.490 +/- 0.000 g cm(-3) [95% confidence interval (CI)] for mod. I, 1.468 +/- 0.002 g cm(-3) (95% CI) for mod. II, and 1.499 +/- 0.004 g cm(-3) (95% CI) for mod. III. It was possible to relate the different modifications given in the literature to one of the three pure crystal forms or to mixtures of two or all three modifications. The thermodynamic relationship among the crystal forms is represented in a semi-schematic energy/temperature diagram. From these data we can conclude that mod. III is thermodynamically stable at absolute zero. It is enantiotropically related to mod. I and mod. II. FTIR and Raman spectra, differential scanning calorimetry curves, and X-ray powder patterns of these crystal forms are depicted for doubtless assignment in the future. The water uptake of the three modifications at 92% relative humidity and 25 degrees C is less than 1%. The differences of the heat capacities and the heats of solution between mod. II and III are not significant, whereas mod. I shows small significant differences compared with the other modifications. In addition, compaction studies of these crystal forms were performed by means of an instrumented hydraulic press. The results show that mod. III should have the best tableting behavior under these conditions. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10737907     DOI: 10.1002/(SICI)1520-6017(200004)89:4<457::AID-JPS3>3.0.CO;2-G

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  40 in total

1.  Crystallization of mannitol below Tg' during freeze-drying in binary and ternary aqueous systems.

Authors:  Abira Pyne; Rahul Surana; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

2.  Effect of vacuum drying on protein-mannitol interactions: the physical state of mannitol and protein structure in the dried state.

Authors:  Vikas K Sharma; Devendra S Kalonia
Journal:  AAPS PharmSciTech       Date:  2004-02-17       Impact factor: 3.246

3.  New respirable and fast dissolving itraconazole dry powder composition for the treatment of invasive pulmonary aspergillosis.

Authors:  Christophe Duret; Nathalie Wauthoz; Thami Sebti; Francis Vanderbist; Karim Amighi
Journal:  Pharm Res       Date:  2012-05-30       Impact factor: 4.200

4.  Influence of ethanol on physical state of freeze-dried mannitol.

Authors:  Akira Takada; Steven L Nail; Masakatsu Yonese
Journal:  Pharm Res       Date:  2009-01-28       Impact factor: 4.200

5.  Aerosol delivery of nanoparticles in uniform mannitol carriers formulated by ultrasonic spray freeze drying.

Authors:  Suzanne M D'Addio; John Gar Yan Chan; Philip Chi Lip Kwok; Bryan R Benson; Robert K Prud'homme; Hak-Kim Chan
Journal:  Pharm Res       Date:  2013-07-27       Impact factor: 4.200

6.  Mutual Influence of Mannitol and Trehalose on Crystallization Behavior in Frozen Solutions.

Authors:  Sampreeti Jena; Raj Suryanarayanan; Alptekin Aksan
Journal:  Pharm Res       Date:  2016-02-23       Impact factor: 4.200

7.  Engineered mannitol ternary additives improve dispersion of lactose-salbutamol sulphate dry powder inhalations.

Authors:  Waseem Kaialy; Ali Nokhodchi
Journal:  AAPS J       Date:  2013-04-17       Impact factor: 4.009

8.  Influence of process conditions on the crystallization and transition of metastable mannitol forms in protein formulations during lyophilization.

Authors:  Wenjin Cao; Yong Xie; Sampathkumar Krishnan; Hong Lin; Margaret Ricci
Journal:  Pharm Res       Date:  2012-08-21       Impact factor: 4.200

9.  Controlled crystallization of the lipophilic drug fenofibrate during freeze-drying: elucidation of the mechanism by in-line Raman spectroscopy.

Authors:  Hans de Waard; Thomas De Beer; Wouter L J Hinrichs; Chris Vervaet; Jean-Paul Remon; Henderik W Frijlink
Journal:  AAPS J       Date:  2010-07-13       Impact factor: 4.009

10.  Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler.

Authors:  Waseem Kaialy; Ali Nokhodchi
Journal:  Pharm Res       Date:  2012-10-16       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.